근접방사선치료용 다목적 팬톰을 이용한 직장 내 선량분석 = The Analysis of Dose in a Rectum by Multipurpose Brachytherapy Phantom

국문 초록 (Abstract)

목 적: 근접방사선 치료시 직장내 선량측정은 치료간(inter-fraction) 직장의 형태가 변화하므로 측정의 재현성을 이
룰 수 없다. 본 연구에서는 근접방사선치료용 다목적 팬톰(Multi Purpose Brachytherapy Phantom, MPBP)을 제작하
여 치료 시와 동일한 조건을 재현하였고 이때 측정한 선량 값을 직장의 부작용을 줄이기 위해 선량최적화에 적용
하고자 하였다. 대상 및 방법: 자궁경부암 근접방사선 치료 시 탄뎀(tandem)과 난형체(ovoid)를 사용한 환자 4명을 대상으로 다이오드 검출기를 이용하여 직장표시 기준점 R1에서 선량측정을 시행하였다. 환자 당 5회씩 총 20회 직장선량을 측정하였다. 그리고 반복 측정 시 다이오드 검출기의 설정 변화(set up variation)를 분석하였다. 그리고 자체 제작된 근접방사선치료용 다목적 팬톰에서 MFA (Multi Function Applicator)를 이용하여 치료 시와 동일한 조건을 재현한 후열형광선량계(TLD)를 이용하여 직장 표시 기준점 좌표 위치에서 선량을 측정하였다. 결 과: 직장 내 다이오드 검출기의 측정 결과 설정 변화는 환자 1의 경우에 Y방향에서 최고 11.25±0.95 mm보였고, 환자 2와 3은 Z 방향에서 각각 9.90±2.40 mm와 20.85±4.50 mm를 나타냈다. 그리고 환자 4는 Z 방향에서 19.15±3.33 mm의 변화를 나타내었다. 또한 다이오드 검출기 위치에 따른 평균선량 값은 122.82±7.96 cGy∼323.78 ± 11.16 cGy로 나타났다. MPBP에서 TLD의 측정 결과는 직장 표시 기준점(R1)에서 환자1과 4는 상대오차가 각각 최고 8.6%와 7.7%를 보였고, 환자2와 3은 각각 1.7%와 1.2%의 오차를 보였다. 그리고 R과 R2에서 측정한 선량 값들은 환자 2의 R 지점을 제외하고 계산값과 비교하여 1.7∼8.6% 높은 값을 나타냈다. 그리고 반복측정으로 인한 위치변화와 그에 따른 선량 값의 변화는 분석하지 않았다. 계산 값과 측정값의 상대오차가 미국의학물리학회 보고서에서 권고한 15% 내에서 잘 일치하는 것으로 분석되었다. 결 론: 자체 제작된 근접치료용 다목적 팬톰(MPBP)은 치료 시와 동일한 조건에서 선량측정의 재현성을 이룰 수 있었고, 직장의 기준점에서 선량을 정확히 분석할 수 있었다. 또한 팬톰에서 측정한 데이터를 이용하여 직장의 부작용을 줄이기 위해 치료 전 선량 최적화를 이루는데 충분한 자료로 활용할 수 있다고 판단되었다.

다국어 초록 (Multilingual Abstract)

Purpose: In this work we designed and made MPBP (Multi Purpose Brachytherapy Phantom). The MPBP enables one to reproduce the same patient set-up in MPBP as the treatment of the patient and we tried to get an exact analysis of rectal doses in the phantom without need of in-vivo dosimetry. Materials and Methods: Dose measurements were tried at a point of rectum 1, the reference point of rectum, with a diode detector for 4 patients treated with tandem and ovoid for a brachytherapy of a cervix cancer. Total 20 times of rectal dose measurements were made with 5 times a patient. The set-up variation of the diode detector was analyzed. The same patient set-ups were reproduced in self-made MPBP and then rectal doses were measured with TLD. Results: The measurement results of the diode detector showed that the set-up variation of the diode detector was the maximum 11.25±0.95 mm in the y-direction for Patient 1 and the maximum 9.90±2.40 mm, 20.85± 4.50 mm, and 19.15±3.33 mm in the z-direction for Patient 2, 3, and 4, respectively. In analyzing the degree of variation in 3 directions the more variation was showed in the z-direction than x- and y-direction except Patient 1. The results of TLD measurements in MPBP showed the relative maximum error of 8.6% and 7.7% at a point of rectum 1 for Patient 1 and 4, respectively and 1.7% and 1.2% for Patient 2 and 3, respectively. The doses measured at R1 and R2 were higher than those calculated except R point of Patient 2. This can be thought to related to the algorithm of dose calculation, whcih corrects for air and water but is guessed not to consider the correction for the scattered rays, but by considering the self-error (±5%) TLD has the relative error of values measured and calculated was analyzed to be in a good agreement within 15%. Conclusion: The reproducibility of dose measurements under the same condition as the treatment could be achieved owing to the self-made MPMP and the dose at the point of interest could be analyzed accurately. If a treatment is performed after achieving dose optimization using the data obtained in the phantom, dose will be able to be minimized to important organs.

목차 (Table of Contents)

• 서 론
• 대상 및 방법
• 결 과
• 고안 및 결론

참고문헌 (Reference)

• 1 "The use of improved radiochromic film for in vivo quality assurance of high dose rate brachytherapy" 25 : 1217-1221, 1998
• 2 "Temperature dependence of commercially available diode detectors" 29 : 622-630, 2002
• 3 "Task Group 40:Comprehensive QA for radiation oncology" 21 : 581-618, 1994
• 4 "Significant rectal and bladder dose reduction via utilization of foley balloon catheters in high-dose-rate tandem and ovoid intracavitary brachytherapy of the uterine cervix" 59 : 174-178, 2004
• 5 "Routine clinical estimation of rectal,rectosigmoidal,and bladder dose from intracavitary brachytherapy in the treatment of carcinoma of the cervix" 7 : 653-660, 1981
• 6 "Rectal thermoluminescent dosimeter measurements using the microSelectron high dose rate afterloader in postoperative intravaginal radiation case" 26 : 341-345, 1992
• 7 "Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy:a dosimetric analysis" 28 : 1243-1250, 1994
• 8 "Late rectal sequlae following definitive radiation therapy for carcinoma of the uterine cervix:a dosimetric analysis" 37 : 351-358, 1997
• 9 "Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix" 32 : 725-734, 1995
• 10 "Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer" 56 : 37-38, 2000
• 11 "Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations" 60 : 273-280, 2001
• 12 "In-vivo rectal dose measurements with diodes to avoid misadministrations during intracavitary high dose rate brachytherapy for carcinoma of the cervix" 26 : 768-770, 1999
• 13 "In-vivo dosimetry for gynecological brachytherapy: physical and clinical considerations" in press 1-8, 2005
• 14 "Dose-Volume analysis and the prevention of radiation sequelae in cervical cancer" 8 : 321-332, 1987
• 15 "Dose and volume specification for reporting intracavitary therapy in gynecology International Commission on Radiation Units and Measurements" md1985
• 16 "Computers in brachytherapy dosimetry" Oxford University press Inc 49-52, 2001
• 17 "Comparison between the calculated and measured dose in the rectum during high dose rate brachytherapy for uterine cervical carcinomas" 20 : 396-404, 2002
• 18 "Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation dose delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer" 62 : 131-137, 2005
• 19 "Calibration of a MOSFET detection system for 6-MV In vivo dosimetry" 40 : 987-993, 1998
• 20 "Bladder and rectum dose defined from MRI base treatment planning for cervix cancer brachytherapy:comparison of dose-volume histograms for organ contours and organ wall,comparison with ICRU rectum and bladder reference point" 68 : 269-276, 2003
• 21 "Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer:In vivo Dosimetric Analysis" 17 : 289-293, 1999